- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02788305
Effect of Maternal Obesity on Labour Induction in Postdate Pregnancy
October 13, 2017 updated by: heba mahmoud ibrahim marie, Kasr El Aini Hospital
This study investigate the progression of labour in 144 normal weight pregnant women (BMI <30) and 144 obese pregnant women (BMI >30) , not in labor admitted for induction of labor.
These women are to be investigated for success of induction of labor.
Study Overview
Detailed Description
- This prospective study will be conducted for 144 obese and 144 non obese ), post date (>41 wks), not in labor.
- Woman is classified as obese if BMI >=30.
- Prolonged pregnancy was defined as delivery on or after (41+0 weeks) of gestation.
- First informed consent will be obtained.
- Determination of gestational age
- Proper history taking, general and abdominal examinations will be done then digital examination will be performed to determine bishop score.
And obstetric U/S scan will be done and by which the following data will be obtained :
- Fetal biometry
- Fetal heart activity
- Presentation
- Localization of the placenta.
- Amount of amniotic fluid.
- Exclude multifetal pregnancy.
- Induction of labor will be done using vaginal misoprostol according to the estimated Bishop score.
Study Type
Observational
Enrollment (Actual)
288
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Greater Cairo
-
Cairo, Greater Cairo, Egypt, 11956
- Kasr wl aini hospitals
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 40 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
144 pregnant women with BMI >= 30 and 144 pregnant women with BMI <30, post date >= 41 wks, not in labor admitted in Kaselaini H for induction of labor.
Description
Inclusion Criteria:
Pregnant woman.
- Post date >= 41 weeks.
- Absent onset of labor.
- Patient acceptance to join the study after signing an informed consent.
Exclusion Criteria:
- Placenta previa and or vasa previa.
- Previous caesarean section(CS).
- Multiple gestation
- Any patient who will refuse to be a part of the study.
- Intra- uterine fetal death (IUFD).
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
non obese
BMI<30.
Misoprostol is given for induction of labour according to Bishop score
|
Misoprostol 25 micrograms every 6 hours will be given to obese and non obese groups
|
|
obese
BMI>30.
Misoprostol is given for induction of labour according to Bishop score
|
Misoprostol 25 micrograms every 6 hours will be given to obese and non obese groups
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
route of delivery vaginal or caesarean section.
Time Frame: 48 hours from the start of induction
|
Partogram is used to access the progress of labour
|
48 hours from the start of induction
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
maternal haemorrhage
Time Frame: 48 hours from the start of induction
|
Calculating number of soaked pads
|
48 hours from the start of induction
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Heba M Marie, M.D., kasrelaini hospital
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
May 1, 2016
Primary Completion (Actual)
May 30, 2017
Study Completion (Actual)
June 30, 2017
Study Registration Dates
First Submitted
May 20, 2016
First Submitted That Met QC Criteria
May 26, 2016
First Posted (Estimate)
June 2, 2016
Study Record Updates
Last Update Posted (Actual)
October 16, 2017
Last Update Submitted That Met QC Criteria
October 13, 2017
Last Verified
October 1, 2017
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 9898 (Other Identifier: CTEP)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Undecided
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
Clinical Trials on Misoprostol
-
Aljazeera HospitalKasr El Aini HospitalUnknown
-
Hospital de Clinicas de Porto AlegreCompletedMiscarriage in First TrimesterBrazil
-
Ferring PharmaceuticalsCompletedCervical Ripening | Labor InductionUnited Kingdom
-
Cairo UniversityCompleted
-
Karolinska InstitutetCompletedFirst Trimester Pregnancy | Surgical Termination of PregnancySweden
-
Medstar Health Research InstituteSociety of Family PlanningCompletedSecond Trimester AbortionsUnited States
-
Northwestern UniversityRecruitingFibroids, Uterine | Hysteroscopy / Methods | Fluid DeficitUnited States
-
CHA UniversityCompleted
-
Hamna KhaliqNot yet recruiting
-
Cairo UniversityNot yet recruitingPregnancy | Labor | Misoprostol | Nulliparous